United States Biotechnology & Medical Research

Monte Rosa Therapeutics Inc (GLUE)

Track

Over the past 90 days, Monte Rosa Therapeutics Inc. has seen significant insider selling activity, with 37 transactions totaling approximately $411,200 in net value. Key executives, including the Chief Medical Officer and Chief Scientific Officer, have executed planned sales. These transactions follow a period where the stock price rose 18.4% leading up to the next earnings report.
Ticker: GLUE Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Monte Rosa Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 16 Jul 2026
Value US$1,087,663.29 | Price 348.14 | Shares 55,117 (-26.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-17 2026-07-16 S Sale
0.9
Warmuth Markus

President & CEO

Executive Director
55,117 -26.0%
348.14
US$1,087,663 		55,117 -26.0% 348.14 US$1,087,663
2026-07-16 2026-07-16 PrS Proposed sale
0.9
MARKUS WARMUTH

Officer

Officer
90,702
154.25
US$3,425,739 		90,702 154.25 US$3,425,739
2026-07-16 2026-07-15 PlS Planned sale
0.6
Champoux Jennifer

Chief Operating Officer

Officer
249 -39.3%
347.80
US$748,955 		249 -39.3% 347.80 US$748,955
2026-07-15 2026-07-15 PrS Proposed sale
0.6
Champoux Jennifer

Officer

Officer
1,000
23.38
US$100,000 		1,000 23.38 US$100,000
2026-07-07 2026-07-06 PlS Planned sale
0.6
Townson Sharon

Chief Scientific Officer

Officer
400 -0.6%
24.13
US$9,652 		400 -0.6% 24.13 US$9,652
2026-07-07 2026-07-06 PlS Planned sale
0.6
Townson Sharon

Chief Scientific Officer

Officer
5,600 -7.6%
23.25
US$130,197 		5,600 -7.6% 23.25 US$130,197
2026-07-01 2026-06-30 PlS Planned sale
2.3
Janku Filip

Chief Medical Officer

Officer
5,407 -8.2%
24.50
US$132,472 		5,407 -8.2% 24.50 US$132,472
2026-06-30 2026-06-30 PrS Proposed sale
2.3
FILIP JANKU

Officer

Officer
5,407
23.90
US$129,227 		5,407 23.90 US$129,227
2026-06-30 2026-06-29 S Sale
Manning Anthony M.
Non-Executive Director
10,000 -100.0%
23.11
US$231,100 		10,000 -100.0% 23.11 US$231,100
2026-06-30 2026-06-29 PlS Planned sale
2.3
Janku Filip

Chief Medical Officer

Officer
6,000 -9.1%
22.95
US$137,700 		6,000 -9.1% 22.95 US$137,700
2026-06-29 2026-06-29 PrS Proposed sale
2.3
FILIP JANKU

Officer

Officer
6,000
22.29
US$133,740 		6,000 22.29 US$133,740
2026-06-29 2026-06-29 PrS Proposed sale
ANTHONY M MANNING

Director

Non-Executive Director
10,000
23.11
US$231,100 		10,000 23.11 US$231,100
2026-06-25 2026-06-24 PlS Planned sale
2.3
Janku Filip

Chief Medical Officer

Officer
30,000 -33.3%
21.42
US$642,681 		30,000 -33.3% 21.42 US$642,681
2026-06-24 2026-06-24 PrS Proposed sale
2.3
FILIP JANKU

Officer

Officer
30,000
20.71
US$621,300 		30,000 20.71 US$621,300
2026-06-25 2026-06-23 PlS Planned sale
2.3
Janku Filip

Chief Medical Officer

Officer
11,845 -16.5%
20.22
US$239,522 		11,845 -16.5% 20.22 US$239,522
2026-06-25 2026-06-23 PlS Planned sale
0.6
Townson Sharon

Chief Scientific Officer

Officer
3,000 -4.2%
20.00
US$60,000 		3,000 -4.2% 20.00 US$60,000
2026-06-25 2026-06-23 PlS Planned sale
0.6
Champoux Jennifer

Chief Operating Officer

Officer
2,175 -3.4%
20.00
US$43,500 		2,175 -3.4% 20.00 US$43,500
2026-06-23 2026-06-23 PrS Proposed sale
2.5
EDMUND DUNN

Officer

Officer
16,665
20.70
US$344,986 		16,665 20.70 US$344,986
2026-06-23 2026-06-23 PrS Proposed sale
2.3
FILIP JANKU

Officer

Officer
11,845
18.67
US$221,146 		11,845 18.67 US$221,146
2026-06-23 2026-06-23 PrS Proposed sale
0.6
Champoux Jennifer

Officer

Officer
2,175
18.41
US$40,042 		2,175 18.41 US$40,042
2026-06-18 2026-06-17 PlS Planned sale
0.6
Champoux Jennifer

Chief Operating Officer

Officer
2,176 -3.4%
19.00
US$41,344 		2,176 -3.4% 19.00 US$41,344
2026-06-18 2026-06-17 PlS Planned sale
0.6
Townson Sharon

Chief Scientific Officer

Officer
3,000 -4.2%
19.00
US$57,000 		3,000 -4.2% 19.00 US$57,000
2026-06-17 2026-06-17 PrS Proposed sale
0.6
Champoux Jennifer

Officer

Officer
2,176
17.93
US$39,005 		2,176 17.93 US$39,005
2026-06-02 2026-06-01 PlS Planned sale
0.9
Warmuth Markus

President & CEO

Executive Director
468 -0.1%
19.73
US$9,232 		468 -0.1% 19.73 US$9,232
2026-06-02 2026-06-01 PlS Planned sale
0.9
Warmuth Markus

President & CEO

Executive Director
468 -0.1%
19.73
US$9,232 		468 -0.1% 19.73 US$9,232
2026-06-02 2026-06-01 PlS Planned sale
0.9
Warmuth Markus

President & CEO

Executive Director
4,998 -0.8%
19.41
US$97,021 		4,998 -0.8% 19.41 US$97,021
2026-06-02 2026-06-01 PlS Planned sale
0.9
Warmuth Markus

President & CEO

Executive Director
4,998 -0.8%
19.41
US$97,021 		4,998 -0.8% 19.41 US$97,021
2026-06-01 2026-06-01 PrS Proposed sale
0.9
Warmuth Markus

Officer

Officer
5,466
19.44
US$106,253 		5,466 19.44 US$106,253
2026-06-01 2026-05-29 PlS Planned sale
0.6
Townson Sharon

Chief Scientific Officer

Officer
6,000 -8.1%
19.87
US$119,220 		6,000 -8.1% 19.87 US$119,220
2026-05-29 2026-05-29 PrS Proposed sale
0.6
SHARON TOWNSON

Officer

Officer
24,000
19.39
US$465,360 		24,000 19.39 US$465,360
2026-05-28 2026-05-27 PlS Planned sale
0.6
Champoux Jennifer

Chief Operating Officer

Officer
2,175 -3.4%
20.00
US$43,500 		2,175 -3.4% 20.00 US$43,500
2026-05-27 2026-05-27 PrS Proposed sale
0.6
Champoux Jennifer

Officer

Officer
2,175
19.33
US$42,043 		2,175 19.33 US$42,043
2026-05-26 2026-05-22 PlS Planned sale
0.6
Champoux Jennifer

Chief Operating Officer

Officer
2,176 -3.4%
19.00
US$41,344 		2,176 -3.4% 19.00 US$41,344
2026-05-22 2026-05-22 PrS Proposed sale
0.6
Champoux Jennifer

Officer

Officer
2,176
18.72
US$40,735 		2,176 18.72 US$40,735
2026-05-22 2026-05-21 S Sale
Manning Anthony M.
Non-Executive Director
10,000 -100.0%
18.01
US$180,100 		10,000 -100.0% 18.01 US$180,100
2026-05-21 2026-05-21 PrS Proposed sale
ANTHONY M MANNING

Director

Non-Executive Director
10,000
18.01
US$180,100 		10,000 18.01 US$180,100
2026-05-21 2026-05-21 PrS Proposed sale
ANTHONY M MANNING

Director

Non-Executive Director
10,000
18.01
US$180,100 		10,000 18.01 US$180,100
2026-06-02 2026-05-01 PrS Proposed sale
0.9
Warmuth Markus

Officer

Officer
5,467
18.92
US$103,447 		5,467 18.92 US$103,447
2026-05-05 2026-05-01 PlS Planned sale
0.9
Warmuth Markus

President & CEO

Executive Director
5,467 -0.9%
18.92
US$103,447 		5,467 -0.9% 18.92 US$103,447
2026-05-01 2026-05-01 PrS Proposed sale
0.9
Warmuth Markus

Officer

Officer
5,467
18,922.01
US$103,446,628 		5,467 18,922.01 US$103,446,628
2026-04-16 2026-04-16 PrS Proposed sale
2.5
EDMUND DUNN

Officer

Officer
18,683
18.50
US$345,636 		18,683 18.50 US$345,636
2026-04-15 2026-04-14 S Sale
0.9
Warmuth Markus

President & CEO

Executive Director
8,000 -1.3%
17.64
US$141,125 		8,000 -1.3% 17.64 US$141,125
2026-04-14 2026-04-14 PrS Proposed sale
0.9
MARKUS WARMUTH

Officer; Director

Executive Director
8,000
17.64
US$141,125 		8,000 17.64 US$141,125
2026-04-13 2026-04-13 PrS Proposed sale
2.5
EDMUND DUNN

Officer

Officer
16,687
18.00
US$300,366 		16,687 18.00 US$300,366
2026-04-10 2026-04-09 S Sale
0.8
Nickson Philip

Chief Business & Legal Officer

Officer
5,845 -9.6%
17.69
US$103,413 		5,845 -9.6% 17.69 US$103,413
2026-04-09 2026-04-09 PrS Proposed sale
0.8
PHILIP NICKSON

Officer

Officer
5,845
17.69
US$103,413 		5,845 17.69 US$103,413
2026-04-08 2026-04-08 PrS Proposed sale
2.5
EDMUND DUNN

Officer

Officer
26,117
17.25
US$450,623 		26,117 17.25 US$450,623
2026-03-05 2026-03-04 S Sale
2.5
Dunn Edmund

Principal Accounting Officer

Officer
139 -0.6%
17.96
US$2,496 		139 -0.6% 17.96 US$2,496
2026-03-04 2026-03-04 PrS Proposed sale
2.5
Dunn Edmund

Officer

Officer
139
17.86
US$2,482 		139 17.86 US$2,482
2026-03-04 2026-03-02 PlS Planned sale
0.9
Warmuth Markus

President & CEO

Executive Director
5,466 -0.9%
17.92
US$97,974 		5,466 -0.9% 17.92 US$97,974
2026-03-02 2026-03-02 S Sale
2.5
Dunn Edmund

Principal Accounting Officer

Officer
536 -2.3%
17.50
US$9,380 		536 -2.3% 17.50 US$9,380
2026-03-02 2026-03-02 PrS Proposed sale
0.9
Warmuth Markus

Officer

Officer
5,466
17.92
US$97,974 		5,466 17.92 US$97,974
2026-03-02 2026-03-02 PrS Proposed sale
2.5
Edmund Dunn

Officer

Officer
536
17.50
US$9,380 		536 17.50 US$9,380
2026-03-02 2026-02-27 S Sale
2.5
Dunn Edmund

Principal Accounting Officer

Officer
25,164 -52.6%
18.10
US$455,506 		25,164 -52.6% 18.10 US$455,506
2026-02-27 2026-02-27 PrS Proposed sale
2.5
Edmund Dunn

Officer

Officer
25,164
18.10
US$455,506 		25,164 18.10 US$455,506
2026-02-24 2026-02-23 S Sale
2.3
Janku Filip

Chief Medical Officer

Officer
9,189 -12.2%
19.50
US$179,161 		9,189 -12.2% 19.50 US$179,161
2026-02-23 2026-02-23 PrS Proposed sale
2.3
FILIP JANKU

Officer

Officer
9,189
19.50
US$179,161 		9,189 19.50 US$179,161
2026-01-09 2026-01-07 PlS Planned sale
0.9
Warmuth Markus

President & CEO

Executive Director
309 -0.0%
24.57
US$7,593 		309 -0.0% 24.57 US$7,593
2026-01-09 2026-01-07 PlS Planned sale
0.9
Warmuth Markus

President & CEO

Executive Director
1,450 -0.2%
23.88
US$34,620 		1,450 -0.2% 23.88 US$34,620
2026-01-09 2026-01-07 PlS Planned sale
0.9
Warmuth Markus

President & CEO

Executive Director
3,707 -0.6%
23.24
US$86,159 		3,707 -0.6% 23.24 US$86,159
2026-01-08 2026-01-07 PrS Proposed sale
0.9
Warmuth Markus

Officer

Officer
5,466
23.49
US$128,372 		5,466 23.49 US$128,372
2026-01-07 2026-01-07 PrS Proposed sale
0.9
Warmuth Markus

Officer

Officer
5,466
23.49
US$128,372 		5,466 23.49 US$128,372
2026-01-05 2026-01-05 PrS Proposed sale
0.9
Warmuth Markus

Officer; Director

Executive Director
10,135
15.17
US$153,759 		10,135 15.17 US$153,759
2026-01-05 2026-01-05 S Sale
2.5
Dunn Edmund

Principal Accounting Officer

Officer
1,039 -4.4%
15.17
US$15,762 		1,039 -4.4% 15.17 US$15,762
2026-01-05 2026-01-05 S Sale
2.3
Janku Filip

Chief Medical Officer

Officer
3,155 -4.0%
15.17
US$47,861 		3,155 -4.0% 15.17 US$47,861
2026-01-05 2026-01-05 S Sale
0.6
Champoux Jennifer

Chief Operating Officer

Officer
2,629 -4.0%
15.17
US$39,882 		2,629 -4.0% 15.17 US$39,882
2026-01-05 2026-01-05 S Sale
0.9
Warmuth Markus

President & CEO

Executive Director
10,135 -1.6%
15.17
US$153,748 		10,135 -1.6% 15.17 US$153,748
2026-01-05 2026-01-05 S Sale
0.8
Nickson Philip

Chief Business & Legal Officer

Officer
3,155 -4.9%
15.17
US$47,861 		3,155 -4.9% 15.17 US$47,861
2026-01-05 2026-01-05 S Sale
0.6
Townson Sharon

Chief Scientific Officer

Officer
3,155 -4.4%
15.17
US$47,861 		3,155 -4.4% 15.17 US$47,861
2025-06-04 2025-06-03 S Sale
2.5
Dunn Edmund

Principal Accounting Officer

Officer
2,062 -8.0%
4.45
US$9,174 		2,062 -8.0% 4.45 US$9,174
2025-03-25 2025-03-24 B Purchase
0.8
Leo Chandra P.
Non-Executive Director
10,000 +inf%
5.84
US$58,383 		10,000 +inf% 5.84 US$58,383
2024-10-30 2024-10-29 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
15,600 -1.0%
9.41
US$146,793 		15,600 -1.0% 9.41 US$146,793
2024-10-30 2024-10-29 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
52,305 -3.2%
9.08
US$475,008 		52,305 -3.2% 9.08 US$475,008
2024-10-30 2024-10-28 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
89,990 -4.3%
9.66
US$869,240 		89,990 -4.3% 9.66 US$869,240
2024-10-28 2024-10-28 PrS Proposed sale
Wallace Owen B.

Officer

Officer
20,000
12.00
US$240,000 		20,000 12.00 US$240,000
Explore more

More insider trading research around Monte Rosa Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America